Sathyaprasad Burjonrappa, MD
- Pediatric-Surgery
Pediatric surgeon Dr. Sathyaprasad Burjonrappa’s passion for caring for children and their families comes from experience and expertise built over 30 years. He has trained at some of the best and busiest centers in the world and incorporated the latest technology in caring for babies and children.
At RWJBarnabas Health, Dr. Burjonrappa offers advanced laparoscopy for congenital conditions such as duodenal atresia, Hirschsprung’s disease, anorectal malformations, and pulmonary malformations. He provides bariatric surgery for obese adolescents at our Center of Excellence, working with an advanced practice provider, a dietitian, and other specialists at Rutgers Robert Wood Johnson Medical School.
Dr. Burjonrappa treats chest wall deformities using the minimally invasive Nuss procedure along with cryoablation. Integration of Enhanced Recovery After Surgery (ERAS) protocols allows for early discharge in both bariatric and pectus repair patients. In collaboration with world-class pediatric oncologists at the Rutgers Cancer Institute, he participates in the latest clinical trials. Rutgers Cancer Institute is one of the few centers in the country that treats advanced melanoma with CAR-T cell therapy. The latest Children’s Oncology Group (COG) protocols are followed in the management of hepatoblastoma, Wilms tumor, and neuroblastoma.
Dr. Burjonrappa’s research on clinical outcomes focuses on pediatric trauma, oncology, and outcomes in pediatric and neonatal surgery. He incorporates the latest surgical innovations in practice and compared outcomes to pre-existing standards. He studies disparities in outcomes based on social or ethnic status to understand the pathophysiology of disease, improve quality of care, and advance innovation in pediatric surgical care. Toward this end, he has studied imaging appropriateness in pediatric trauma, developed new indices to appropriately triage trauma patients for better outcomes, studied the genetic basis of rare cancers such as rhabdomyosarcoma, considered nephron-sparing surgery in Wilms Tumor, and developed modifications of the Tokyo Guidelines for pediatric gallbladder disease amongst other projects.